Your browser doesn't support javascript.
loading
Response to letter entitled: Re: Oral cavity adjuvant therapy (OCAT) - a phase III, randomised controlled trial of surgery followed by conventional radiotherapy (5 fr/wk) versus concurrent CT-RT versus accelerated radiotherapy (6fr/wk) in locally advanced, resectable, squamous cell carcinoma of oral cavity.
Ghosh-Laskar, Sarbani; Chatterjee, Abhishek; Sinha, Shwetabh.
Affiliation
  • Ghosh-Laskar S; Department of Radiation Oncology Tata Memorial Centre Homi Bhabha National University (HBNI), Mumbai, India. Electronic address: sarbanilaskar@gmail.com.
  • Chatterjee A; Department of Radiation Oncology Tata Memorial Centre Homi Bhabha National University (HBNI), Mumbai, India.
  • Sinha S; Department of Radiation Oncology Tata Memorial Centre Homi Bhabha National University (HBNI), Mumbai, India.
Eur J Cancer ; 189: 112922, 2023 08.
Article in En | MEDLINE | ID: mdl-37321931
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell Type of study: Clinical_trials Limits: Humans Language: En Journal: Eur J Cancer Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell Type of study: Clinical_trials Limits: Humans Language: En Journal: Eur J Cancer Year: 2023 Document type: Article